- Home
- EVTL vs TLSA Comparison
EVTL vs TLSA Comparison
Compare EVTL & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTL
- TLSA
- Stock Information
- Founded
- EVTL 2016
- TLSA 2013
- Country
- EVTL United Kingdom
- TLSA United Kingdom
- Employees
- EVTL N/A
- TLSA N/A
- Industry
- EVTL Aerospace
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- EVTL Industrials
- TLSA Health Care
- Exchange
- EVTL Nasdaq
- TLSA Nasdaq
- Market Cap
- EVTL 444.1M
- TLSA 187.0M
- IPO Year
- EVTL N/A
- TLSA 2000
- Fundamental
- Price
- EVTL $5.22
- TLSA $1.77
- Analyst Decision
- EVTL Strong Buy
- TLSA
- Analyst Count
- EVTL 8
- TLSA 0
- Target Price
- EVTL $11.43
- TLSA N/A
- AVG Volume (30 Days)
- EVTL 1.1M
- TLSA 325.5K
- Earning Date
- EVTL 08-05-2025
- TLSA 05-06-2025
- Dividend Yield
- EVTL N/A
- TLSA N/A
- EPS Growth
- EVTL N/A
- TLSA N/A
- EPS
- EVTL N/A
- TLSA N/A
- Revenue
- EVTL N/A
- TLSA N/A
- Revenue This Year
- EVTL N/A
- TLSA N/A
- Revenue Next Year
- EVTL N/A
- TLSA N/A
- P/E Ratio
- EVTL N/A
- TLSA N/A
- Revenue Growth
- EVTL N/A
- TLSA N/A
- 52 Week Low
- EVTL $2.76
- TLSA $0.63
- 52 Week High
- EVTL $15.99
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- EVTL 52.33
- TLSA 48.40
- Support Level
- EVTL $4.52
- TLSA $1.63
- Resistance Level
- EVTL $5.54
- TLSA $1.88
- Average True Range (ATR)
- EVTL 0.37
- TLSA 0.16
- MACD
- EVTL 0.07
- TLSA -0.00
- Stochastic Oscillator
- EVTL 72.88
- TLSA 65.38
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.